nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Appropriate Relevancy and Reliability of Real-World Data for the Utilization of Regulatory Submission
|
Bando, Hideaki |
|
|
23 |
2 |
p. 111-117 |
artikel |
2 |
Complete Obstruction, a Real Risk Factor: A Comprehensive Study on Obstruction in Stage IIA Colon Cancer With Propensity Score Matching Analysis
|
Oh, Soo Young |
|
|
23 |
2 |
p. 135-146.e3 |
artikel |
3 |
Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review
|
Miller, Eric D. |
|
|
23 |
2 |
p. 160-173 |
artikel |
4 |
Editorial Board
|
|
|
|
23 |
2 |
p. A1 |
artikel |
5 |
Immunotherapy Rechallenge After Checkpoint Inhibitor Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review
|
Geusens, Dorien |
|
|
23 |
2 |
p. 194-197 |
artikel |
6 |
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E
|
Chen, Eric X. |
|
|
23 |
2 |
p. 183-193 |
artikel |
7 |
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D
|
Kim, Richard |
|
|
23 |
2 |
p. 118-127.e6 |
artikel |
8 |
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study
|
Yuki, Satoshi |
|
|
23 |
2 |
p. 147-159.e7 |
artikel |
9 |
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF V600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program
|
Kotani, Daisuke |
|
|
23 |
2 |
p. 174-182.e6 |
artikel |
10 |
Table of contents
|
|
|
|
23 |
2 |
p. A3-A4 |
artikel |
11 |
The Effect of (Chemo)Radiotherapy on Enlarged Lateral Lymph Nodes in Patients With Locally Advanced Rectal Cancer
|
van der Zijden, Charlène J. |
|
|
23 |
2 |
p. 128-134.e1 |
artikel |